
C7  - pp. 599-625
TI  - Index
SN  - 9780470410301
UR  - https://doi.org/10.1002/9780470640500.index
DO  - doi:10.1002/9780470640500.index
SP  - 599-625
PY  - 2011
ER  - 

TY  - JOUR
TI  - Clinical care and other categories posters: Audit
JO  - Diabetic Medicine
VL  - 26
IS  - s1
SN  - 9780470410301
UR  - https://doi.org/10.1111/j.1464-5491.2009.02663.x
DO  - doi:10.1111/j.1464-5491.2009.02663.x
SP  - 79
EP  - 199
PY  - 2009
ER  - 

C7  - pp. 68-116
TI  - B
SN  - 9780470035450
UR  - https://doi.org/10.1002/9780470056981.ch2
DO  - doi:10.1002/9780470056981.ch2
SP  - 68-116
PY  - 2009
ER  - 

TY  - JOUR
TI  - Poster Sessions - Late Breaking
JO  - Transplant International
VL  - 24
IS  - s2
SN  - 9780470035450
UR  - https://doi.org/10.1111/j.1432-2277.2011.01352.x
DO  - doi:10.1111/j.1432-2277.2011.01352.x
SP  - 322
EP  - 352
PY  - 2011
ER  - 

C7  - pp. 160-212
TI  - Medication Development for Stimulant Addiction
SN  - 9780470614167
UR  - https://doi.org/10.1002/9781118943670.ch6
DO  - doi:10.1002/9781118943670.ch6
SP  - 160-212
KW  - σ receptor systems
KW  - catalyst pharmaceutical partners (CPP)
KW  - cocaine
KW  - medication development
KW  - methamphetamine
KW  - norepinephrine
KW  - opioid
KW  - serotonin
KW  - stimulant addiction
PY  - 2011
AB  - Summary Cocaine is an intense, euphoria-producing stimulant drug with strong addictive potential, and derived from the leaves of the coca tree (Erythroxylum coca). The primary action of cocaine in inducing addiction is binding to the dopamine transporter (DAT) and preventing reuptake of synaptic dopamine although cocaine has about equal functional activity at all three monoamine transporters. Methamphetamine is a schedule II stimulant under the controlled substances act, which means that it has a high potential for abuse and limited medical use. Most drug strategies for the development of medications to treat stimulant addiction have focused on methods to reduce the effects of excess dopamine. These include partial antagonists at dopamine receptors, D3 agonists, or indirect modulation by interaction with the opioid, serotonin, norepinephrine, and σ receptor systems. Catalyst pharmaceutical partners (CPP) are investigating vigabatrin for the treatment of cocaine addiction.
ER  - 

C7  - pp. 323-376
TI  - The Aromatic Amino Acids: Phenylalanine, Tyrosine and Tryptophan
SN  - 9780470661512
UR  - https://doi.org/10.1002/9781118357514.ch9
DO  - doi:10.1002/9781118357514.ch9
SP  - 323-376
KW  - aromatic amino acids, phenylalanine, tyrosine, tryptophan biosynthesis
KW  - aromatic amino acids, dietary, essential amino acids for animals
KW  - mammals, and lack of shikimate pathway, enzymes as targets for herbicides
KW  - shikimic acid, chemical synthesis of Tamiflu, a neuraminidase inhibitor
KW  - dehydroquinate dehydratase, bifunctional with shikimate dehydrogenase
KW  - phenylpropanoid pathway in lignin biosynthesis
KW  - phenylalanine hydroxylase, for tyrosine synthesis
KW  - phenylalanine hydroxylase, inhibition by catecholamines chelating catalytic iron
KW  - mammalian catabolism of phenylalanine, hydroxylation to tyrosine
KW  - kynurenine pathway, tryptophan catabolism and synthesis in NAD/NADP
PY  - 2011
AB  - Summary This chapter contains sections titled: Biosynthesis of phenylalanine, tyrosine and tryptophan Metabolism of phenylalanine and tyrosine Catabolism of phenylalanine and tyrosine Metabolism of tryptophan Quinone cofactors in amine oxidases Further reading
ER  - 

C7  - pp. 179-211
TI  - The Haemostatic System
SN  - 9781118829912
UR  - https://doi.org/10.1002/9781118829875.ch8
DO  - doi:10.1002/9781118829875.ch8
SP  - 179-211
KW  - adenosine diphosphate
KW  - cardiovascular disease
KW  - dietary components
KW  - fibrinolysis inhibitors
KW  - fibrinolytic system
KW  - genes coding
KW  - haemostatic system
KW  - obesity diabetes
KW  - platelets
PY  - 2011
AB  - Summary The haemostatic or coagulant system is designed primarily to prevent bleeding and haemorrhage following injury to blood vessels, although some of its constituent proteins have additional roles in inflammation, angiogenesis, and tissue repair. This chapter describes the function and components of the haemostatic system and its role in the pathogenesis of cardiovascular disease (CVD). It explores the effect of variants in genes coding for proteins in the haemostatic system on cardiovascular risk. The chapter describes the effect of dietary components on the haemostatic system, both directly and via the development of chronic conditions, such as obesity and diabetes. Platelets have a key function in normal haemostasis and are activated by a number of agonists, particularly thrombin, collagen, adenosine diphosphate (ADP), and also adrenaline and serotonin, some of which act synergistically in vivo with other agonists. The fibrinolytic system regulates the degradation of the fibrin matrix. It consists of fibrinolytic factors and fibrinolysis inhibitors.
ER  - 

TY  - JOUR
TI  - Abstracts 200–407
JO  - Hepatology
JA  - Hepatology
VL  - 52
IS  - S1
SN  - 9781118829912
UR  - https://doi.org/10.1002/hep.23979
DO  - doi:10.1002/hep.23979
SP  - 422A
EP  - 522A
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts from the Twenty-Second Annual Meeting of the Japanese Society for Artificial Organs and Tissues November 9–10, 1984 Osaka, Japan
JO  - Artificial Organs
VL  - 9
IS  - 3
SN  - 9781118829912
UR  - https://doi.org/10.1111/j.1525-1594.1985.tb04395.x
DO  - doi:10.1111/j.1525-1594.1985.tb04395.x
SP  - 288
EP  - 338
PY  - 1985
ER  - 

TY  - JOUR
TI  - Author and Subject Indexes
JO  - Wound Repair and Regeneration
VL  - 9
IS  - 6
SN  - 9781118829912
UR  - https://doi.org/10.1046/j.1524-475X.2001.00538.x
DO  - doi:10.1046/j.1524-475X.2001.00538.x
SP  - 538
EP  - 548
PY  - 2001
ER  - 

TY  - JOUR
AU  - d'Arcy, Richard
AU  - Tirelli, Nicola
C8  - PAT-14-009
TI  - Fishing for fire: strategies for biological targeting and criteria for material design in anti-inflammatory therapies
JO  - Polymers for Advanced Technologies
JA  - Polym. Adv. Technol.
VL  - 25
IS  - 5
SN  - 9781118829912
UR  - https://doi.org/10.1002/pat.3264
DO  - doi:10.1002/pat.3264
SP  - 478
EP  - 498
KW  - inflammation
KW  - stimuli responsive
KW  - targeted delivery
KW  - nanocarriers
KW  - prodrugs
PY  - 2014
AB  - Inflammatory pathologies are a growing burden for developed societies, and the tools offered by medicinal chemistry/biotechnology have provided us with an armamentarium of active principles. Unfortunately, most of them are marred by very significant side effects that can be summarized by two words: poor targeting (of cells, of tissues, etc.). This review provides a broad overview of the approaches and of the materials used to obtain an inflammation-responsive or inflammation-targeted behavior, which can be used to improve anti-inflammatory therapies. Here, we first define the biochemical factors that may allow both to recognize and to target an inflamed environment, for example, the leakiness of capillaries, the presence of oxidants (reactive oxygen species), or of upregulated receptors/enzymes. We then review the systems that have shown the possibility to accumulate in inflamed tissues, respond to its stimuli, or bind to activated inflammatory cells, separately discussing payload/carrier (guest/host) systems and macromolecular prodrugs/conjugates. Copyright ? 2014 John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - E-Posters
JO  - Australian and New Zealand Journal of Obstetrics and Gynaecology
JA  - Aust N Z J Obstet Gynaecol
VL  - 57
IS  - S1
SN  - 9781118829912
UR  - https://doi.org/10.1111/ajo.12725
DO  - doi:10.1111/ajo.12725
SP  - 30
EP  - 70
PY  - 2017
ER  - 

TY  - JOUR
TI  - Free Papers
JO  - Journal of Gastroenterology and Hepatology
VL  - 19
IS  - s5
SN  - 9781118829912
UR  - https://doi.org/10.1111/j.1440-1746.2004.t01-1-03624.x
DO  - doi:10.1111/j.1440-1746.2004.t01-1-03624.x
SP  - A296
EP  - A323
PY  - 2004
ER  - 

TY  - JOUR
TI  - Workshops
JO  - Journal of the European Academy of Dermatology and Venereology
VL  - 9
IS  - S1
SN  - 9781118829912
UR  - https://doi.org/10.1111/j.1468-3083.1997.tb01077.x
DO  - doi:10.1111/j.1468-3083.1997.tb01077.x
SP  - S79
EP  - S111
PY  - 1997
ER  - 

TY  - JOUR
TI  - Abstracts Twenty-Sixth Annual Meeting American College of Clinical Pharmacology
JO  - The Journal of Clinical Pharmacology
VL  - 37
IS  - 9
SN  - 9781118829912
UR  - https://doi.org/10.1002/j.1552-4604.1997.tb05636.x
DO  - doi:10.1002/j.1552-4604.1997.tb05636.x
SP  - 858
EP  - 878
PY  - 1997
ER  - 

TY  - JOUR
TI  - BDA ABSTRACTS
JO  - Diabetic Medicine
VL  - 7
IS  - S1
SN  - 9781118829912
UR  - https://doi.org/10.1111/j.1464-5491.1990.tb02142.x
DO  - doi:10.1111/j.1464-5491.1990.tb02142.x
SP  - 1A
EP  - 38A
PY  - 1990
ER  - 

TY  - JOUR
TI  - Full Issue Article Volume 16, Issue 3
JO  - Fisheries
JA  - Fisheries
VL  - 16
IS  - 3
SN  - 9781118829912
UR  - https://doi.org/10.1577/1548-8446-16-3
DO  - doi:10.1577/1548-8446-16-3
SP  - 1
EP  - 79
PY  - 1991
ER  - 

TY  - JOUR
TI  - American Association of Anatomists. Seventy-fifth annual session; The University of Minnesota Medical School, March 20, 21, 22, 23, 1962. Officers, abstracts, demonstrations
JO  - The Anatomical Record
JA  - Anat. Rec.
VL  - 142
IS  - 2
SN  - 9781118829912
UR  - https://doi.org/10.1002/ar.1091420213
DO  - doi:10.1002/ar.1091420213
SP  - 207
EP  - 352
PY  - 1962
ER  - 

TY  - JOUR
TI  - Thematic Poster Sessions – Monday
JO  - Allergy
VL  - 66
IS  - s94
SN  - 9781118829912
UR  - https://doi.org/10.1111/j.1398-9995.2011.02607.x
DO  - doi:10.1111/j.1398-9995.2011.02607.x
SP  - 320
EP  - 481
PY  - 2011
ER  - 

TY  - JOUR
TI  - American Association of Anatomists one hundred and fourth annual meeting
JO  - The Anatomical Record
JA  - Anat. Rec.
VL  - 229
IS  - 4
SN  - 9781118829912
UR  - https://doi.org/10.1002/ar.1092290418
DO  - doi:10.1002/ar.1092290418
SP  - A1
EP  - A97
PY  - 1991
ER  - 
